Background Little information has been reported on regional and time trends of human
papillomavirus (HPV) prevalence rates of oropharyngeal cancer (OPC) and non‐OPC …

Recent data demonstrate that human papillomavirus also plays a role in cancers other than
ano-genital cancers, specifically head and neck cancers, and non-cancerous conditions …

Purpose Previous studies estimate translation of research evidence into practice takes 17
years. However, this estimate is not specific to cancer control evidence-based practices …

Background Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative …

Background Coverage levels for many recommended adult vaccinations are low. The cost-
effectiveness research literature on adult vaccinations has not been synthesized in recent …

Objective To assess the cost effectiveness of including preadolescent boys in a routine
human papillomavirus (HPV) vaccination programme for preadolescent girls. Design Cost …

Intense research activity in HPV modelling over this decade has prompted the development
of additional guidelines to those for general modelling. A specific framework is required to …

Time is an important aspect of health economic evaluation, as the timing and duration of
clinical events, healthcare interventions and their consequences all affect estimated costs …

Introduction: Human papillomavirus (HPV) is one of the world's most common sexually
transmitted infections, and has been associated with a number of cervical and non-cervical …

Objective To estimate the incremental delivery cost of human papillomavirus (HPV)
vaccination of young adolescent girls in Peru, Uganda and Viet Nam. Methods Data were …